Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis.
暂无分享,去创建一个
S. Okada | Saowaluk Saisomboon | R. Kariya | K. Sawanyawisuth | C. Pairojkul | S. Wongkham | K. Vaeteewoottacharn | S. Jitrapakdee | Atit Silsirivanit | Piyanard Boonnate | U. Cha'on | V. Luvira | Y. Chamgramol | Wunchana Seubwai | U. Cha’on | Vor Luvira
[1] P. Sakornsakolpat,et al. Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma , 2022, iScience.
[2] D. Hanahan. Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.
[3] N. Khuntikeo,et al. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression , 2021, Frontiers in Pharmacology.
[4] R. Kariya,et al. Five-(Tetradecyloxy)-2-furoic Acid Alleviates Cholangiocarcinoma Growth by Inhibition of Cell-cycle Progression and Induction of Apoptosis , 2021, AntiCancer Research.
[5] J. Swinnen,et al. Lipid metabolism in cancer: New perspectives and emerging mechanisms. , 2021, Developmental cell.
[6] Jia V. Li,et al. Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma , 2020, Cancer & metabolism.
[7] Laura Herrero,et al. Inhibitors of lipogenic enzymes as a potential therapy against cancer , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] B. Teh,et al. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient , 2020, Human Cell.
[9] J. Ferlay,et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012 , 2020, Cancer.
[10] A. Schulze,et al. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. , 2019, Cell metabolism.
[11] R. Kariya,et al. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model , 2019, Cells.
[12] Man Li,et al. AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression , 2019, Journal of Neuroinflammation.
[13] Kshitij Srivastava,et al. Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence. , 2017, Cell metabolism.
[14] O. Werz,et al. Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition[S] , 2017, Journal of Lipid Research.
[15] Y. Pomyen,et al. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. , 2017, Cancer cell.
[16] R. Shaw,et al. AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. , 2017, Molecular cell.
[17] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[18] J. Pfefferkorn,et al. Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells , 2017, PloS one.
[19] Sathesh Bhat,et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small cell lung cancer in preclinical models , 2016, Nature Medicine.
[20] K. Sawanyawisuth,et al. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB , 2016, Scientific Reports.
[21] G. Gores,et al. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans , 2016, Hepatology.
[22] K. Boberg,et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) , 2016, Nature Reviews Gastroenterology &Hepatology.
[23] Hong-Yang Wang,et al. Acetyl‐coenzyme A carboxylase alpha promotion of glucose‐mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients , 2016, Hepatology.
[24] N. Chamadol,et al. Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study. , 2016, Asian Pacific journal of cancer prevention : APJCP.
[25] Hidemasa Bono,et al. CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites , 2014, Bioinform..
[26] S. Okada,et al. Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy , 2014, PloS one.
[27] Sharon Nofech-Mozes,et al. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. , 2014, Archives of pathology & laboratory medicine.
[28] P. Puigserver,et al. Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylationa , 2014, Molecular metabolism.
[29] J. Dyck,et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin–sensitizing effects of metformin , 2013, Nature Medicine.
[30] A. Schulze,et al. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development , 2013, Disease Models & Mechanisms.
[31] J. Swinnen,et al. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. , 2013, Progress in lipid research.
[32] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[33] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[34] E. Maser,et al. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. , 2012, Recent patents on anti-cancer drug discovery.
[35] Itzhak Avital,et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. , 2012, Gastroenterology.
[36] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[37] S. Kridel,et al. Metabolic Regulation of Invadopodia and Invasion by Acetyl-CoA Carboxylase 1 and De novo Lipogenesis , 2012, PloS one.
[38] Song-Cheol Kim,et al. Lipid profiles for intrahepatic cholangiocarcinoma identified using matrix-assisted laser desorption/ionization mass spectrometry. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[39] D. Hardie. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. , 2011, Genes & development.
[40] E. Bess,et al. Nitric Oxide-Induced Activation of the AMP-Activated Protein Kinase α2 Subunit Attenuates IκB Kinase Activity and Inflammatory Responses in Endothelial Cells , 2011, PloS one.
[41] C. Semenkovich,et al. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter , 2011, Trends in Endocrinology & Metabolism.
[42] Sebastian Munck,et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. , 2010, Cancer research.
[43] David Saggerson,et al. Malonyl-CoA, a key signaling molecule in mammalian cells. , 2008, Annual review of nutrition.
[44] C. Pairojkul,et al. Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.
[45] L. Nelles,et al. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition , 2007, Oncogene.
[46] J. L. Smith,et al. Malonyl coenzyme A affects insulin-stimulated glucose transport in myotubes , 2007, Archives of physiology and biochemistry.
[47] Kunihiro Suzuki,et al. Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.
[48] G. Lenoir,et al. Acetyl-CoA Carboxylase α Is Essential to Breast Cancer Cell Survival , 2006 .
[49] J. Swinnen,et al. RNA Interference–Mediated Silencing of the Acetyl-CoA-Carboxylase-α Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells , 2005 .
[50] M. Miwa,et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). , 2005, World journal of gastroenterology.
[51] L. Bresler*,et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. , 2001, The Journal of clinical endocrinology and metabolism.
[52] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.
[53] V. Titapant,et al. A high incidence of liver cancer in Khon Kaen Province, Thailand. , 1990, The Southeast Asian journal of tropical medicine and public health.
[54] J. McGarry,et al. The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. , 1978, The Journal of biological chemistry.